DUNHAM TRUST Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$910K Hold
1,200
– – 0.41% 27
2026
Q2
$748K Buy
+1,200
New +$817K 0.34% 32
2025
Q4
$926K Buy
+1,200
New +$815K 0.59% 19

Other funds holding REGN

DUNHAM TRUST Co's REGN Position: Q3 2026 in Review

DUNHAM TRUST Co held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 1,200 shares worth $910K. The position accounts for 0.41% of the portfolio, ranked #27.

DUNHAM TRUST Co first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $926K in Q4 2025. 1,409 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • DUNHAM TRUST Co held 1,200 shares of Regeneron Pharmaceuticals worth $910K as of Q3 2026.
  • DUNHAM TRUST Co left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.41% of DUNHAM TRUST Co's portfolio in Q3 2026, its #27 holding.
  • DUNHAM TRUST Co first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • DUNHAM TRUST Co's Regeneron Pharmaceuticals position peaked at $926K in Q4 2025.
  • 1,409 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on DUNHAM TRUST Co's 13F filing for Q3 2026, filed 16 Nov 2026.